Are maca (Lepidium meyenii) and aguaje (Mauritia flexuosa) safe to use concomitantly with oral minoxidil?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 12, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

No Known Drug Interactions Between Maca/Aguaje and Oral Minoxidil

There is no documented evidence of drug interactions between maca (Lepidium meyenii), aguaje (Mauritia flexuosa), and oral minoxidil, making concurrent use likely safe from an interaction standpoint. However, specific cardiovascular considerations warrant attention given minoxidil's mechanism of action.

Key Safety Considerations

Blood Pressure Effects

The primary concern with combining these supplements centers on blood pressure modulation:

  • Oral minoxidil is a potent peripheral vasodilator that lowers blood pressure through ATP-sensitive potassium channel activation, with effects beginning 30-60 minutes post-ingestion 1

  • Maca has demonstrated a moderate effect on blood pressure in at least one study, where high-dose maca powder (0.6 g/day) caused diastolic blood pressure increases 2

  • No published data exists on aguaje's cardiovascular effects or drug interactions

The Critical Issue: Additive Hypotensive Risk

If maca or aguaje possess any blood pressure-lowering properties (which remains unstudied), combining them with oral minoxidil could theoretically potentiate hypotensive effects. This matters because:

  • Low-dose oral minoxidil (LDOM) already causes problematic hypotension in some patients, particularly women at doses as low as 0.25-0.5 mg/day 1
  • Symptomatic hypotension (dizziness, lightheadedness) occurred in 1.7% of patients on LDOM in a large safety study 3
  • The guidelines explicitly warn that "any unwanted decrease in BP may last days" 1

Practical Clinical Approach

Baseline Assessment

Before combining these supplements with oral minoxidil:

  • Measure baseline blood pressure and pulse before starting minoxidil 1, 4
  • Consider these supplements as precautionary factors if baseline BP is already <90/60 mm Hg 4

Monitoring Protocol

Check BP and pulse before and 2 hours after the first combined dose (when minoxidil's effect peaks) 1. This timing captures:

  • Peak plasma minoxidil levels (~156.6 ng/mL at 30-60 minutes with 5 mg dose) 1
  • Maximum hemodynamic impact

Warning Signs Requiring Immediate Action

Stop all medications and seek emergency care if experiencing:

  • Chest pain (requires urgent/emergency evaluation) 1
  • Severe dizziness or lightheadedness 1
  • Shortness of breath (may indicate rare pericardial effusion) 1

Dose-Dependent Risk Stratification

Lower minoxidil doses carry less cardiovascular risk:

  • Start women at 0.5-1.25 mg/day, men at 2.5 mg/day 1
  • Systemic adverse effects led to discontinuation in only 1.7% of 1404 patients 3
  • Life-threatening events are rare at low doses, though pericardial effusion signals exist even at ≤1.25 mg 5

Common Pitfalls to Avoid

  1. Don't assume "natural" means safe: Maca caused AST elevation and blood pressure changes at 0.6 g/day, effects reversed by silymarin co-administration 2

  2. Don't ignore the maca dose paradox: The study showing BP increases used relatively low maca doses (0.6 g/day), while higher doses in combination (2.4 g/day with silymarin) showed no adverse effects 2

  3. Don't overlook individual variability: Some patients, especially women of low weight or with cardiovascular history, are exquisitely sensitive to minoxidil's BP effects 1

Evidence Gaps

Critical limitation: No studies have specifically examined maca or aguaje interactions with minoxidil. The safety assessment is based on:

  • Minoxidil's well-characterized pharmacology [1-6]
  • Limited maca cardiovascular data 7, 2
  • Complete absence of aguaje interaction data

Bottom Line Recommendation

Concurrent use appears acceptable with appropriate monitoring, given:

  • No documented interactions exist
  • LDOM has a favorable safety profile (only 1.7% discontinuation rate for adverse effects) 3
  • Simple BP monitoring can detect problems early

However, exercise heightened caution if:

  • Baseline BP <90/60 mm Hg
  • Patient is female, low weight, or has cardiovascular history
  • Using higher maca doses (>0.6 g/day based on available data)

The absence of evidence is not evidence of safety—implement the 2-hour post-dose BP check as your safety net 1.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.